DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Nafcillin (Nafcillin) - Renal Failure - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Renal Failure (5)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Nafcillin where reactions include renal failure. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Nafcillin side effects in 31 year old female

Reported by a physician from United States on 2012-08-24

Patient: 31 year old female

Reactions: Coagulopathy, Disseminated Intravascular Coagulation, Pyrexia, Pulmonary Oedema, Endocarditis, Hypoxia, Epistaxis, Right Ventricular Failure, Mechanical Ventilation, Metabolic Acidosis, Pneumonia, Hypotension, Pulmonary Arterial Wedge Pressure Increased, Myopathy, Bacteraemia, Subarachnoid Haemorrhage, Haemorrhage, Pulmonary Arterial Hypertension, Adrenal Insufficiency, Abdominal Distension, Ischaemic Hepatitis, Thrombocytopenia, Fluid Overload, Device Related Sepsis, Dyspnoea, Atrial Flutter, Condition Aggravated, Rash, Subdural Haemorrhage, Cardiogenic Shock, Blood Glucose Decreased, Renal Failure, Respiratory Failure, Respiratory Acidosis, Ventricular Fibrillation

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Epoprostenol Sodium
    Dosage: 30 ng/kg, per min
    Start date: 2010-10-19
    End date: 2012-01-01

Epoprostenol Sodium
    Dosage: 33 ng/kg, per min
    Indication: Pulmonary Arterial Hypertension
    Start date: 2012-01-01
    End date: 2012-06-17

Nafcillin

Tracleer
    Dosage: unk
    Administration route: Oral
    Indication: Pulmonary Arterial Hypertension
    Start date: 2008-04-08

Other drugs received by patient: Remeron; Digoxin; Ferrous Sulfate TAB; Revatio; Zantac; Potassium Chloride; Hibiclens; Coumadin; Spironolactone; Celexa; Zofran; Furosemide; Oxycodone HCL; Oxygen



Possible Nafcillin side effects in

Reported by a consumer/non-health professional from United States on 2012-07-12

Patient:

Reactions: Pulmonary Hypertension, Haemorrhage, Coagulopathy, Pyrexia, Pulmonary Oedema, Hypoxia, Adrenal Insufficiency, Abdominal Distension, Endocarditis, Ischaemic Hepatitis, Thrombocytopenia, Epistaxis, Fluid Overload, Device Related Sepsis, Right Ventricular Failure, Mechanical Ventilation, Dyspnoea, Pneumonia, Metabolic Acidosis, Atrial Flutter, Rash, Pulmonary Arterial Wedge Pressure Increased, Cardiogenic Shock, Subdural Haemorrhage, Myopathy, Blood Glucose Decreased, Renal Failure, Respiratory Acidosis, Respiratory Failure, Bacteraemia, Subarachnoid Haemorrhage, Ventricular Fibrillation

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Tracleer
    Dosage: unk
    Administration route: Oral
    Indication: Pulmonary Arterial Hypertension
    Start date: 2008-04-08

Epoprostenol Sodium
    Dosage: 33 ng/kg, per min
    Indication: Pulmonary Arterial Hypertension
    Start date: 2012-01-01
    End date: 2012-06-17

Epoprostenol Sodium
    Dosage: 30 ng/kg, per min
    Start date: 2010-10-19
    End date: 2012-01-01

Nafcillin

Other drugs received by patient: Furosemide; Potassium Chloride; Oxycodone HCL; Celexa; Remeron; Coumadin; Digoxin; Hibiclens; Zofran; Zantac; Ferrous Sulfate TAB; Revatio; Spironolactone; Oxygen



Possible Nafcillin side effects in

Reported by a pharmacist from United States on 2012-07-02

Patient:

Reactions: Pulmonary Hypertension, Haemorrhage, Coagulopathy, Pyrexia, Endocarditis, Hypoxia, Abdominal Distension, Pulmonary Oedema, Adrenal Insufficiency, Ischaemic Hepatitis, Thrombocytopenia, Epistaxis, Mechanical Ventilation, Fluid Overload, Right Ventricular Failure, Pneumonia, Metabolic Acidosis, Dyspnoea, Atrial Flutter, Pulmonary Arterial Wedge Pressure Increased, Rash, Cardiogenic Shock, Subdural Haemorrhage, Myopathy, Blood Glucose Decreased, Renal Failure, Subarachnoid Haemorrhage, Respiratory Failure, Respiratory Acidosis, Bacteraemia, Ventricular Fibrillation

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Epoprostenol Sodium
    Dosage: 33 ng/kg, per min
    Start date: 2012-01-01
    End date: 2012-06-17

Tracleer
    Dosage: unk
    Administration route: Oral
    Indication: Pulmonary Arterial Hypertension
    Start date: 2008-04-08

Nafcillin

Epoprostenol Sodium
    Dosage: 30 ng/kg, per min
    Indication: Pulmonary Arterial Hypertension
    Start date: 2010-10-19
    End date: 2012-01-01

Other drugs received by patient: Remeron; Spironolactone; Hibiclens; Oxygen; Revatio; Oxycodone HCL; Zantac; Furosemide; Ferrous Sulfate TAB; Digoxin; Zofran; Celexa; Coumadin; Potassium Chloride



Possible Nafcillin side effects in 52 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-13

Patient: 52 year old male, weighing 100.0 kg (220.0 pounds)

Reactions: Contusion, Lymphadenopathy, Pulmonary Embolism, Transaminases Increased, Mycobacterium Avium Complex Infection, Psoas Abscess, Malaise, Ecchymosis, Oedema Peripheral, Gastrointestinal Sounds Abnormal, Diverticular Perforation, White Blood Cell Count Increased, Back Pain, Cushingoid, Pain in Extremity, General Physical Health Deterioration, Abnormal Behaviour, Skin Striae, Subclavian Vein Thrombosis, Subdiaphragmatic Abscess, Irritability, Gastrointestinal Inflammation, Mental Status Changes, Skin Hyperpigmentation, Fatigue, Intervertebral Discitis, Abdominal Distension, Adrenal Adenoma, Muscular Weakness, Axillary Vein Thrombosis, Hyperadrenocorticism, Paraspinal Abscess, Dysstasia, Renal Failure, Deep Vein Thrombosis, Adrenal Disorder

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Nafcillin
    Indication: Cellulitis

Daptomycin
    Indication: Staphylococcal Bacteraemia

Nafcillin
    Indication: Staphylococcal Bacteraemia

Daptomycin
    Dosage: unk
    Indication: Cellulitis Staphylococcal
    Start date: 2007-03-01
    End date: 2007-03-01

Other drugs received by patient: Warfarin Sodium; Furosemide; Aspirin; Insulin; Potassium Chloride; Metformin HCL; Spironolactone; Amlodipine; Risedronate Sodium; Oxycodone HCL and Acetaminophen; Hydralazine HCL; Metoprolol Tartrate; Valsartan; Stool Softener



Possible Nafcillin side effects in 52 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-07

Patient: 52 year old male

Reactions: Lymphadenopathy, Contusion, Pulmonary Embolism, Transaminases Increased, Mycobacterium Avium Complex Infection, Psoas Abscess, Malaise, Ecchymosis, Oedema Peripheral, Gastrointestinal Sounds Abnormal, Nelson's Syndrome, White Blood Cell Count Increased, Diverticular Perforation, Cushingoid, Back Pain, Pain in Extremity, General Physical Health Deterioration, Abnormal Behaviour, Skin Striae, Subclavian Vein Thrombosis, Subdiaphragmatic Abscess, Irritability, Mental Status Changes, Gastrointestinal Inflammation, Skin Hyperpigmentation, Fatigue, Intervertebral Discitis, Abdominal Distension, Adrenal Adenoma, Axillary Vein Thrombosis, Muscular Weakness, Hyperadrenocorticism, Renal Failure, Paraspinal Abscess, Dysstasia, Adrenal Disorder, Deep Vein Thrombosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Nafcillin
    Indication: Cellulitis

Nafcillin
    Indication: Staphylococcal Bacteraemia

Daptomycin
    Indication: Staphylococcal Bacteraemia

Daptomycin
    Indication: Cellulitis

Other drugs received by patient: Spironolactone; Risedronate Sodium; Furosemide; Acetylsalicylic Acid SRT; Oxycodone HCL and Acetaminophen; Amlodipine; Valsartan; Warfarin Sodium; Hydralazine HCL; Metoprolol; Metformin HCL; Insulin; Potassium Chloride; Stool Softener

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017